In 2005 the federal Nuclear Regulatory Commission renewed the CT nuclear reactors’ licenses, allowing them to continue ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...

A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Researchers have reported that the widespread use of glucagon-like peptide-1 receptor agonists – prescribed for diabetes and ...

The plant still produces roughly one-third of all electricity generated within CT, causing great interest and speculation ...

A new study warns that GLP-1 weight-loss drugs like Ozempic and Wegovy may cause false cancer signals on PET-CT scans, ...

Popular weight-loss drugs Ozempic and others can affect medical scans. New research shows these medications interfere with ...

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

New research suggests weight loss jabs like GLP-1s could affect cancer scans. These drugs might make scans appear abnormal, ...

WEIGHT loss jabs could interfere with vital scans, potentially leading to cancer misdiagnosis, scientists say. Whether they’re taken for diabetes or weight loss, through the NHS or ...

A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested. Weight-loss drugs such as Ozempic and Wegovy have soared in popularity. About one in eight U.S. adults ...